Ultragenyx Pharmaceutical Inc

General

Total Cases2
Active Cases2
Patents21
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/27/24
NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE, ULTRAGENYX PHARMACEUTICAL INC. (SULLIVAN, SARAH) (Entered: 09/27/2024)
09/27/24
NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE, ULTRAGENYX PHARMACEUTICAL INC. (SULLIVAN, SARAH) (Entered: 09/27/2024)
09/27/24
NOTICE of Appearance by WILLIAM C. BATON on behalf of BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE, ULTRAGENYX PHARMACEUTICAL INC. (BATON, WILLIAM) (Entered: 09/27/2024)
09/27/24
NOTICE of Appearance by WILLIAM C. BATON on behalf of BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE, ULTRAGENYX PHARMACEUTICAL INC. (BATON, WILLIAM) (Entered: 09/27/2024)
09/27/24
Case Assigned to Magistrate Judge Michael A. Hammer. (ak, ) (Entered: 09/27/2024)
09/27/24
Case Assigned to Magistrate Judge Michael A. Hammer. (ak, ) (Entered: 09/27/2024)
09/26/24
Corporate Disclosure Statement by BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE. (LIZZA, CHARLES) (Entered: 09/26/2024)
09/26/24
Corporate Disclosure Statement by BAYLOR RESEARCH INSTITUTE D/B/A BAYLOR SCOTT & WHITE RESEARCH INSTITUTE. (LIZZA, CHARLES) (Entered: 09/26/2024)
09/26/24
Corporate Disclosure Statement by ULTRAGENYX PHARMACEUTICAL INC.. (LIZZA, CHARLES) (Entered: 09/26/2024)
09/26/24
Corporate Disclosure Statement by ULTRAGENYX PHARMACEUTICAL INC.. (LIZZA, CHARLES) (Entered: 09/26/2024)